{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:16:37Z","timestamp":1788264997135,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jcjo.2025.03.008","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:42:30Z","timestamp":1744735350000},"page":"279-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors associated with disease relapse in healing\/healed arterial injury and biopsy-proven giant cell arteritis"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0994-3278","authenticated-orcid":false,"given":"Wei","family":"Sim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Mouhanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danah","family":"Albreiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2025.03.008_bib0001","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3899\/jrheum.181127","article-title":"Factors associated with relapse and dependence on glucocorticoids in giant cell arteritis","volume":"47","author":"Dumont","year":"2020","journal-title":"J Rheumatol [Internet]"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102930","article-title":"Epidemiology of major relapse in giant cell arteritis: a study-level meta-analysis","volume":"21","author":"Aussedat","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0003","doi-asserted-by":"crossref","first-page":"e3210","DOI":"10.1097\/MD.0000000000003210","article-title":"Do early diagnosis and glucocorticoid treatment decrease the risk of permanent visual loss and early relapses in giant cell arteritis: a prospective longitudinal study","volume":"95","author":"Hocevar","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0004","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MD.0000000000000033","article-title":"Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients","volume":"93","author":"Alba","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/rheumatology\/kev348","article-title":"Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study","volume":"55","author":"Labarca","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0006","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/1756-185X.13642","article-title":"Body mass index associates with disease relapse in patients with giant cell arteritis","volume":"22","author":"Matsumoto","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0007","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/acr.23901","article-title":"Prevalence of giant cell arteritis relapse in patients treated with glucocorticoids: a meta-analysis","volume":"72","author":"Mainbourg","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0008","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MD.0b013e31821c4fad","article-title":"Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from Northwestern Spain","volume":"90","author":"Martinez-Lado","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0009","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.semarthrit.2020.04.004","article-title":"Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study","volume":"50","author":"Muratore","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0010","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3899\/jrheum.120511","article-title":"Giant cell arteritis with or without aortitis at diagnosis. A retrospective study of 22 patients with long-term follow-up","volume":"39","author":"Espitia","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211009029","article-title":"Large-vessel involvement is predictive of multiple relapses in giant cell arteritis","volume":"13","author":"de Mornac","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0012","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcjo.2017.07.019","article-title":"Characterization of serological markers of healed\/healing arteritis and giant cell arteritis","volume":"53","author":"Kansal","year":"2018","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0013","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.sjopt.2014.10.001","article-title":"Review of Giant cell arteritis","volume":"29","author":"Chacko","year":"2015","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0014","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10067-006-0332-0","article-title":"Relationship between histological subtypes and clinical characteristics at presentation and outcome in biopsy-proven temporal arteritis. Identification of a relatively benign subgroup","volume":"26","author":"ter Borg","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3899\/jrheum.110317","article-title":"Clinical course and management of a consecutive series of patients with \u201chealed temporal arteritis","volume":"39","author":"Lee","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2023.107574","article-title":"Consensus statement on the processing, interpretation and reporting of temporal artery biopsy for arteritis","volume":"67","author":"Nair","year":"2023","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jcjo.2025.03.008_bib0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780400105","article-title":"Disease patterns and tissue cytokine profiles in giant cell arteritis","volume":"40","author":"Weyand","year":"1997","journal-title":"Arthritis Rheum"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000841822500136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000841822500136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:59:42Z","timestamp":1759539582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000841822500136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S000841822500136X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.03.008","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors associated with disease relapse in healing\/healed arterial injury and biopsy-proven giant cell arteritis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}